Meeting the needs of those who need it most
HEMA Biologics is a privately held biopharmaceutical company focused on the rarest bleeding disorders.
Our goal is to meet the needs of patients living with these disorders, support the broader community that cares for them, and bring meaningful therapies and services to help better their daily lives.
We take our mission seriously
We believe that our focused approach can help advance our mission to improve the health and care for people living with the rarest bleeding disorders. We are committed to:
Rooted in Europe, making a difference in the US
We take pride in the heritage of LFB SA, a French state-owned company and the developer and manufacturer of our investigational therapies.
LFB SA is an innovative European biopharmaceutical company dedicated to the development, manufacture, and safety of therapeutic proteins.
HEMA Biologics is excited to partner with LFB SA in the further development and potential commercialization of these therapies in the United States.